Tepoditamab (Anti-CLEC12A / CD371)
Product Specifications
CAS Number
2044679-53-8
Synonyms
MCLA 117
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Tepoditamab (Anti-CLEC12A / CD371) is a bispecific monoclonal antibody that targets and binds to CLEC12A of myeloid cells and CD3 of cytotoxic T cells. Tepoditamab kills AML leukaemia mother cells and AML leukaemia stem cells, induces T cell-mediated proliferative lysis of AML cells and can be used in acute myeloid leukaemia (AML) research. MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040633-100 1x 100 µL
Von Willebrand Factor (3E2D10), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880906-100 1x 100 µL
Cytokeratin 7 (KRT7/760 + KRT7/903), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details